Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Francois Boutignon
Introduction
Francois Boutignon is a notable inventor based in Clermont-Ferrand, France. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of teverelix-TFA compositions. With a total of 5 patents to his name, Boutignon's work has garnered attention for its innovative approaches to drug formulation.
Latest Patents
Francois Boutignon's latest patents include a reconstitutable teverelix-TFA composition. This invention relates to a composition that maintains a predefined molar ratio of teverelix to trifluoroacetate, which is below the ratio required for microcrystal formation. The composition remains stable during storage at temperatures around 2-8° C. Upon reconstitution, a fixed amount of trifluoroacetate can be added, achieving an exact molar ratio to obtain a fluid, milky microcrystalline aqueous teverelix-TFA suspension. Another significant patent is the teverelix-TFA composition, which has a molar ratio of teverelix to trifluoroacetate of at least 1:2.2. This specific ratio prevents undesirable gel formation and provides a homogeneous suspension, resulting in unique bioavailability of teverelix.
Career Highlights
Throughout his career, Boutignon has worked with various companies, including Antev Limited and Aptys Pharmaceuticals. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical innovations.
Collaborations
Francois Boutignon has collaborated with notable individuals in his field, including Guy Poland and Finn Larsen. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Francois Boutignon's contributions to the field of pharmaceutical compositions demonstrate his innovative spirit and dedication to advancing drug formulation technologies. His patents reflect a commitment to improving the stability and bioavailability of important pharmaceutical compounds.